Bio

For the past 25 years, Laura Labeots has helped companies develop and defend their Intellectual Property portfolios. She has a Ph.D. in Organic Chemistry from Northwestern University where she worked with Professor Robert Letsinger. She did postdoctoral studies at the University of Chicago where later she became a Research Faculty Member. Her legal practice includes patent drafting and prosecution, litigation, opinion work (freedom-to-operate, patentability, invalidity, and infringement analyses), due diligence, licensing, trade secrets, trademark prosecution and litigation, and inter partes review proceedings before the U.S. Patent and Trademark Office. Laura partners with companies to develop effective patent strategies on a wide range of matters including genetic testing, diagnostics, disease detection, vaccines, antibodies, nucleic acids, siRNA, miRNA, CRISPR, antisense oligonucleotides, RNAi, stem cells, pharmaceuticals, nanotechnology, chemical synthesis, polymeric materials, nutrition, agriculture/plants, veterinary medicine, orthopedic/dental/medical devices, light-shaping diffusers, holographic components, geotextiles, tools, and instrumentation. In addition, she advises companies on issues relating to subject matter eligibility for nucleic acid-based inventions, genetics, and personalized medicine patents. Some of the pharmaceutical agents that Laura has worked on include these: metastasis inhibitors, antifungal antibiotics, anticoagulants, macrolides, rifamycin antibiotics, proton pump inhibitors, reverse transcriptase inhibitors, anticonvulsants, estrogen receptor antagonists, antipsychotics, topical analgesics, appetite stimulants, attention deficit hyperactivity disorder modulators, acetylcholinesterase inhibitors, atypical antibiotics, dopamine agonists and psychostimulants. In addition to her legal experience, Laura has significant industrial experience as a Research Chemist for more than a decade. She helped develop diagnostic products for Abbott Laboratories based on modified nucleic acids. She also worked for Kraft Foods Company, where she co-invented several patents on synthetic fat substitutes, including U.S. Patent No. 5,424,420; European Patent No. 064765; Norway Patent No. 0943707; Finland Patent No. 944625; and Canadian Patent No. 2,131,786. She also worked for Exelon.